|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8719963D0
(en)
|
1987-08-24 |
1987-09-30 |
Cattaneo A |
Recombinant dna products
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
US6476198B1
(en)
|
1993-07-13 |
2002-11-05 |
The Scripps Research Institute |
Multispecific and multivalent antigen-binding polypeptide molecules
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
AU697387C
(en)
|
1994-09-16 |
2006-03-02 |
Austin Research Institute Cancer and Anti-inflammatory Syndicate No 1 |
Polypeptides with Fc binding ability
|
|
US6808709B1
(en)
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
JP2001511122A
(ja)
|
1997-01-10 |
2001-08-07 |
エピサイト ファーマシューティカル，インコーポレイテッド |
新規な上皮組織標的化薬剤
|
|
US6045774A
(en)
|
1997-01-10 |
2000-04-04 |
Epicyte Pharmaceutical Inc. |
J chain polypeptide targeting molecule linked to an imaging agent
|
|
US6284536B1
(en)
|
1998-04-20 |
2001-09-04 |
The Regents Of The University Of California |
Modified immunoglobin molecules and methods for use thereof
|
|
DE60042785D1
(de)
|
1999-06-09 |
2009-10-01 |
Immunomedics Inc |
Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
|
|
MXPA02010011A
(es)
*
|
2000-04-11 |
2003-04-25 |
Genentech Inc |
Anticuerpos multivalentes y usos para los mismos.
|
|
AU2001257445B2
(en)
|
2000-04-28 |
2006-11-02 |
Planet Biotechnology, Inc. |
Immunoadhesin for the prevention of rhinovirus infection
|
|
EP1366366B1
(en)
|
2000-05-10 |
2010-10-20 |
Signe BioPharma Inc. |
Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
CN100522999C
(zh)
|
2002-02-14 |
2009-08-05 |
免疫医疗公司 |
抗cd20抗体及其融合蛋白和使用方法
|
|
ATE477276T1
(de)
|
2002-03-01 |
2010-08-15 |
Immunomedics Inc |
Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen
|
|
WO2003086459A1
(en)
|
2002-04-12 |
2003-10-23 |
Medarex, Inc. |
Methods of treatement using ctla-4 antibodies
|
|
KR101143035B1
(ko)
|
2002-06-14 |
2012-05-08 |
이뮤노메딕스, 인코오포레이티드 |
단클론 항체 ｈＰＡＭ4
|
|
PT1523496E
(pt)
*
|
2002-07-18 |
2011-09-29 |
Merus B V |
Produção de misturas de anticorpos de forma recombinante
|
|
PT1558648E
(pt)
*
|
2002-10-17 |
2012-04-23 |
Genmab As |
Anticorpos monoclonais humanos contra cd20
|
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
ATE469920T1
(de)
|
2003-05-23 |
2010-06-15 |
Crucell Holland Bv |
Herstellung von rekombinanten igm in den per.c6 zellen
|
|
TW200510532A
(en)
|
2003-07-15 |
2005-03-16 |
Chugai Pharmaceutical Co Ltd |
IgM production by transformed cell and method of quantifying the same
|
|
EP1648512A4
(en)
|
2003-07-31 |
2009-01-21 |
Immunomedics Inc |
ANTI-CD19 ANTIBODIES
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
WO2005035573A1
(ja)
|
2003-10-09 |
2005-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
タンパク質溶液の安定化方法
|
|
KR20120125634A
(ko)
|
2003-10-16 |
2012-11-16 |
마이크로메트 에이지 |
다중특이적 탈면역화된 ｃｄ3-바인더
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
WO2005077981A2
(en)
*
|
2003-12-22 |
2005-08-25 |
Xencor, Inc. |
Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
|
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
CA2586285A1
(en)
|
2004-11-05 |
2006-05-18 |
Palingen, Inc. |
Antibody induced cell membrane wounding
|
|
WO2006094192A2
(en)
|
2005-03-03 |
2006-09-08 |
Immunomedics, Inc. |
Humanized l243 antibodies
|
|
US8349332B2
(en)
*
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
|
CN101282993A
(zh)
*
|
2005-06-02 |
2008-10-08 |
阿斯利康公司 |
针对cd20的抗体和其用途
|
|
CN101263158B
(zh)
*
|
2005-08-03 |
2011-12-28 |
人类多克隆治疗股份有限公司 |
表达人源化免疫球蛋白的转基因动物中b细胞凋亡的抑制
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
KR101410521B1
(ko)
*
|
2005-12-16 |
2014-06-20 |
아이비씨 파마슈티컬스, 인코퍼레이티드 |
다가 면역글로불린-계 생동성 어셈블리들
|
|
AU2006327175A1
(en)
|
2005-12-21 |
2007-06-28 |
Medimmune, Llc |
Epha2 bite molecules and uses thereof
|
|
CN105837690A
(zh)
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
EP2087111A2
(en)
*
|
2007-03-19 |
2009-08-12 |
Medimmune Limited |
Polypeptide variants
|
|
US20100298223A1
(en)
|
2007-05-02 |
2010-11-25 |
Dietmar Rudolf Fries |
Fibrinogen for treatment of bleeding in trauma and platelet disorders
|
|
CN201229536Y
(zh)
|
2008-07-03 |
2009-04-29 |
鸿富锦精密工业（深圳）有限公司 |
电脑机箱
|
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
WO2011090762A1
(en)
|
2009-12-29 |
2011-07-28 |
Emergent Product Development Seattle, Llc |
Heterodimer binding proteins and uses thereof
|
|
TW201129384A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
|
JP2013519682A
(ja)
|
2010-02-11 |
2013-05-30 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
抗ｃｄ２００抗体を使用する治療方法
|
|
AU2011318567B2
(en)
|
2010-10-19 |
2017-02-09 |
Mayo Foundation For Medical Education And Research |
Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
|
|
EP2655415A4
(en)
|
2010-12-22 |
2016-03-09 |
Abbvie Inc |
THREE VARIABLE DOMAIN LINK PROTEINS AND USES THEREOF
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
EP2791169B1
(en)
|
2011-12-16 |
2017-07-19 |
Synthon Biopharmaceuticals B.V. |
Compounds and methods for treating inflammatory diseases
|
|
IN2014MN01781A
(cg-RX-API-DMAC7.html)
|
2012-02-08 |
2015-07-03 |
Igm Biosciences Inc |
|
|
CA2869023A1
(en)
*
|
2012-04-05 |
2013-10-10 |
Gottfried Himmler |
Secretory immunoglobulin complex
|
|
WO2013158748A1
(en)
|
2012-04-17 |
2013-10-24 |
Mayo Foundation For Medical Education And Research |
Human antibodies and specific binding sequences thereof for use in stroke and ischemia or ischemic conditions
|
|
US20150175678A1
(en)
|
2012-06-15 |
2015-06-25 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
|
EP2880057A4
(en)
|
2012-08-02 |
2016-03-23 |
Jn Biosciences Llc |
MULTIMERIZED FUSION ANTIBODIES OR PROTEINS THROUGH THE MUTATION OF A CYSTEINE AND A PIECE OF TAIL
|
|
JOP20200236A1
(ar)
*
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
WO2014124457A1
(en)
|
2013-02-11 |
2014-08-14 |
University Of Louisville Research Foundation, Inc. |
Methods for producing antibodies
|
|
US9487773B2
(en)
|
2013-03-01 |
2016-11-08 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Cell-based methods for coupling protein interactions and binding molecule selection
|
|
GB201311487D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Bispecific molecules
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
EP3041862B1
(en)
|
2013-09-05 |
2020-05-06 |
IGM Biosciences, Inc. |
Constant chain modified bispecific, penta- and hexavalent ig-m antibodies
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
KR102056963B1
(ko)
|
2013-12-30 |
2019-12-17 |
에피맙 바이오테라퓨틱스 인코포레이티드 |
Fabs-인-탠덤 면역글로불린 및 이의 용도
|
|
SG11201605691VA
(en)
|
2014-01-16 |
2016-08-30 |
Mario Umberto Francesco Mondelli |
Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
|
|
CN105992772A
(zh)
|
2014-02-10 |
2016-10-05 |
Igm生命科学股份有限公司 |
IgA多特异性结合分子
|
|
KR102442436B1
(ko)
|
2014-03-14 |
2022-09-15 |
노파르티스 아게 |
Lag-3에 대한 항체 분자 및 그의 용도
|
|
AU2015240595B2
(en)
|
2014-04-03 |
2020-02-27 |
Igm Biosciences, Inc. |
Modified J-chain
|
|
IL308212A
(en)
|
2015-01-20 |
2024-01-01 |
Igm Biosciences Inc |
Tumor necrosis factor-α receptor binding molecules and their uses
|
|
CA2980751A1
(en)
|
2015-03-25 |
2016-09-29 |
Stephen F. Carroll |
Multi-valent hepatitis b virus antigen binding molecules and uses thereof
|
|
HK1245675A1
(zh)
|
2015-04-17 |
2018-08-31 |
Igm Biosciences, Inc. |
多价人免疫缺陷病毒抗原结合分子及其用途
|
|
WO2015151081A2
(en)
|
2015-07-12 |
2015-10-08 |
Suzhou M-Conj Biotech Co., Ltd |
Bridge linkers for conjugation of a cell-binding molecule
|
|
ES2819870T3
(es)
|
2015-09-30 |
2021-04-19 |
Igm Biosciences Inc |
Moléculas de unión con cadena J modificada
|
|
SI3355913T1
(sl)
|
2015-09-30 |
2025-01-31 |
Igm Biosciences, Inc. |
Vezalne molekule z modificirano j-verigo
|
|
PT3455257T
(pt)
|
2016-05-09 |
2021-12-06 |
Igm Biosciences Inc |
Anticorpos anti-pd-l1
|
|
MX2019000796A
(es)
|
2016-07-20 |
2019-06-03 |
Igm Biosciences Inc |
Moleculas multimericas de union a ox40 y usos de las mismas.
|
|
CA3030659A1
(en)
|
2016-07-20 |
2018-01-25 |
Igm Biosciences, Inc. |
Multimeric gitr binding molecules and uses thereof
|
|
CA3030634A1
(en)
|
2016-07-20 |
2018-01-25 |
Igm Biosciences, Inc. |
Multimeric cd137/4-1bb binding molecules and uses thereof
|
|
AU2017299610B2
(en)
|
2016-07-20 |
2022-09-29 |
Igm Biosciences, Inc. |
Multimeric CD40 binding molecules and uses thereof
|
|
WO2018187702A2
(en)
|
2017-04-07 |
2018-10-11 |
Igm Biosciences A/S |
Modified human igm constant regions for modulation of complement-dependent cytolysis effector function
|
|
EP3759229A4
(en)
|
2018-02-26 |
2021-12-29 |
IGM Biosciences Inc. |
Use of a multimeric anti-dr5 binding molecule in combination with a chemotherapeutic agent for treating cancer
|
|
CA3091144A1
(en)
|
2018-03-01 |
2019-09-06 |
Igm Biosciences, Inc. |
Igm fc and j-chain mutations that affect igm serum half-life
|
|
SG11202103720XA
(en)
|
2018-10-23 |
2021-05-28 |
Igm Biosciences Inc |
MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES
|